Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The physiological rationale for oral insulin administration.

Arbit E.

Diabetes Technol Ther. 2004 Aug;6(4):510-7. Review.

PMID:
15321008
2.

Oral insulin: the rationale for this approach and current developments.

Arbit E, Kidron M.

J Diabetes Sci Technol. 2009 May 1;3(3):562-7. Review.

3.

Nanoparticle strategies for the oral delivery of insulin.

Damgé C, Reis CP, Maincent P.

Expert Opin Drug Deliv. 2008 Jan;5(1):45-68. Review.

PMID:
18095928
4.

[Inhaled insulin, new perspective for insulin therapy].

Radermecker RP, Sélam JL.

Rev Med Liege. 2005 May-Jun;60(5-6):355-60. Review. French.

PMID:
16035294
5.

[Biotechnological and administration innovations in insulin therapy].

Verge D.

Med Sci (Paris). 2004 Nov;20(11):986-98. Review. French.

6.

Clinical evaluation of inhaled insulin.

Mastrandrea LD, Quattrin T.

Adv Drug Deliv Rev. 2006 Oct 31;58(9-10):1061-75. Epub 2006 Aug 17. Review.

PMID:
17070613
7.

[Treatment strategy for elderly diabetic patient with insulin or GLP-1 receptor agonist].

Ando Y.

Nihon Rinsho. 2013 Nov;71(11):1993-8. Review. Japanese.

PMID:
24397172
8.

Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.

Petrak F, Herpertz S, Stridde E, Pfützner A.

Diabetes Technol Ther. 2013 Aug;15(8):703-11. doi: 10.1089/dia.2012.0257. Epub 2013 Jul 11.

PMID:
23844571
9.

Diabetes medications update.

Childs BP.

Kans Nurse. 2004 May;79(5):4-6. No abstract available.

PMID:
15216607
10.

Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.

Wong CY, Martinez J, Dass CR.

J Pharm Pharmacol. 2016 Sep;68(9):1093-108. doi: 10.1111/jphp.12607. Epub 2016 Jun 30. Review.

PMID:
27364922
11.

Eligen insulin--a system for the oral delivery of insulin for diabetes.

Hoffman A, Qadri B.

IDrugs. 2008 Jun;11(6):433-41. Review.

PMID:
18509785
12.

Sliding scale insulin.

Lorber DL.

Diabetes Care. 2001 Nov;24(11):2011-2. No abstract available.

PMID:
11679484
13.

Inhaled insulin--does it become reality?

Siekmeier R, Scheuch G.

J Physiol Pharmacol. 2008 Dec;59 Suppl 6:81-113. Review.

PMID:
19218634
14.

Closer to ideal insulin action: ultra fast acting insulins.

Cengiz E.

Panminerva Med. 2013 Sep;55(3):269-75. Review.

PMID:
24088800
15.

Inhaled insulin: new technology, new possibilities.

Bellary S, Barnett AH.

Int J Clin Pract. 2006 Jun;60(6):728-34. Review.

PMID:
16805759
16.

Alternative routes of insulin delivery.

Krishnankutty RK, Mathew A, Sedimbi SK, Suryanarayan S, Sanjeevi CB.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Oct;34(10):933-48. Review.

17.

Technosphere insulin: an inhaled prandial insulin product.

Neumiller JJ, Campbell RK.

BioDrugs. 2010 Jun;24(3):165-72. doi: 10.2165/11536700-000000000-00000. Review.

PMID:
20462282
18.

Inhaled dry powder insulin for the treatment of diabetes mellitus.

Setter SM, Levien TL, Iltz JL, Odegard PS, Neumiller JJ, Baker DE, Campbell RK.

Clin Ther. 2007 May;29(5):795-813. Review.

PMID:
17697900
19.

Insulin lispro: a fast-acting insulin analog.

Noble SL, Johnston E, Walton B.

Am Fam Physician. 1998 Jan 15;57(2):279-86, 289-92. Review.

20.

Technosphere insulin: inhaled prandial insulin.

Setji TL, Hong BD, Feinglos MN.

Expert Opin Biol Ther. 2016;16(1):111-7. doi: 10.1517/14712598.2016.1121230. Epub 2015 Dec 11. Review.

PMID:
26567896

Supplemental Content

Support Center